News | July 08, 2009

Susan G. Komen Funds Research on Preventing Cancer

July 8, 2009 - The Susan G. Komen for the Cure, a leading breast cancer organization, is announcing millions of dollars in long-term grant funding for research on whether individuals can prevent development of their own cancers.

The foundation is asking the scientific community for proposals for long-term research grants - some as large as $5 million - to study everything from the role of natural products to diets to breast cancer vaccines. The foundation aims to work on strategies to prevent breast cancer entirely, or at least pinpoint the environmental and lifestyle issues that may contribute to breast cancer.

The research will be funded through Komen's Promise Grants: multiyear, multimillion dollar projects geared to answer the toughest questions in breast cancer science today.

Introduced in 2008, Promise Grants require collaboration across a wide range of disciplines - scientists, medical professionals, caregivers, public health specialists and advocates - who normally may not work together. These teams conduct research with the highest potential to deliver treatments for breast cancer more quickly and for this new Promise Grant to find ways to prevent breast cancer.

Komen's $450 million in research funding since its founding in 1982 has touched every major development in breast cancer treatments during the past 27 years. In the last three years alone, Komen has invested more than $230 million in research projects in the U.S. and internationally.

For more information: www5.komen.org/researchgrants/grantprograms.html

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
The MOZART Supra Specimen Tomosynthesis System is the latest generation of 3-D imaging for breast cancer surgery.
News | Breast Imaging | November 08, 2018
KUBTEC announced the launch of a new innovation in the treatment of breast cancer. The Mozart Supra Specimen...
Feature | Breast Imaging | November 07, 2018 | By Jeff Zagoudis
Breast imaging technology has experienced major growth over the last decade or so, and a new report suggests the mark
Philips’ Compressed SENSE technology helps shorten MRI exams by eliminating redundant radiofrequency signals from the acquisition phase. The software reconstructs any missing  information to maintain high image quality. (Images courtesy of Philips/University Hospital Cologne)

Philips’ Compressed SENSE technology helps shorten MRI exams by eliminating redundant radiofrequency signals from the acquisition phase. The software reconstructs any missing information to maintain high image quality. (Images courtesy of Philips/University Hospital Cologne)

Feature | Breast Imaging | November 05, 2018 | By Jeff Zagoudis
The incidence of breast cancer is rising globally, with an estimated 1 in 8 women diagnosed in their lifetime and 40,...
Volpara Enterprise Cloud Reaches 1 Million Mammograms Stored
News | Mammography | October 31, 2018
Volpara Solutions announced that the data stored in the Volpara Enterprise cloud now exceeds 1 million mammographic...
Philips Debuts Integrated Breast Ultrasound Solution
News | Ultrasound Women's Health | October 26, 2018
Philips announced what it calls its ultimate ultrasound solution for breast assessment, available with the Philips Epiq...
Etta Pisano Named American College of Radiology Chief Research Officer
News | Radiology Business | October 25, 2018
October 25, 2018 — Breast imaging research pioneer Etta Pisano, M.D., FACR, has been named...
News | Brachytherapy Systems, Women's Healthcare | October 25, 2018
iCAD Inc. announced new clinical research demonstrating positive outcomes supporting the use of the Xoft Axxent...